Covered recipient · General Payments record
SANDRA L MAHONEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$2,097.74
- Reported across 92 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $815.43 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $304.51 | 13 |
| Novo Nordisk AS | $210.93 | 8 |
| Astellas Pharma US Inc | $74.77 | 3 |
| Lilly USA, LLC | $57.39 | 3 |
| Hologic Sales and Service, LLC | $36.68 | 1 |
| Alexion Pharmaceuticals, Inc. | $30.15 | 1 |
| Daiichi Sankyo Inc. | $29.38 | 1 |
| QOL Medical, LLC | $22.02 | 1 |
| Acerta Pharma LLC | $18.35 | 1 |
| Antares Pharma, Inc. | $16.28 | 1 |
| PFIZER INC. | $14.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.25 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578063 | CMS |
| ABBVIE INC. | $80.90 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578065 | CMS |
| ABBVIE INC. | $18.95 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578067 | CMS |
| ABBVIE INC. | $23.97 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578069 | CMS |
| ABBVIE INC. | $15.96 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578071 | CMS |
| ABBVIE INC. | $16.22 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578073 | CMS |
| ABBVIE INC. | $23.46 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578075 | CMS |
| ABBVIE INC. | $18.50 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578077 | CMS |
| ABBVIE INC. | $17.78 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578079 | CMS |
| ABBVIE INC. | $13.30 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578081 | CMS |
| ABBVIE INC. | $13.41 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578083 | CMS |
| ABBVIE INC. | $14.23 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578085 | CMS |
| ABBVIE INC. | $30.58 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107578087 | CMS |
| Alexion Pharmaceuticals, Inc. | $30.15 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093997746 | CMS |
| Antares Pharma, Inc. | $16.28 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146513878 | CMS |
| Astellas Pharma US Inc | $23.43 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139495586 | CMS |
| Astellas Pharma US Inc | $25.42 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139510763 | CMS |
| Astellas Pharma US Inc | $25.92 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139531824 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.35 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104703585 | CMS |
| Daiichi Sankyo Inc. | $29.38 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089451330 | CMS |
| Hologic Sales and Service, LLC | $36.68 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084877750 | CMS |
| Lilly USA, LLC | $18.67 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135938148 | CMS |
| Lilly USA, LLC | $16.32 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135942710 | CMS |
| Lilly USA, LLC | $22.40 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135958331 | CMS |
| Novo Nordisk Inc | $18.38 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100408661 | CMS |
| Novo Nordisk Inc | $15.25 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100452908 | CMS |
| Novo Nordisk Inc | $2.75 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100263218 | CMS |
| Novo Nordisk Inc | $14.63 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100459196 | CMS |
| Novo Nordisk Inc | $125.89 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100445749 | CMS |
| Novo Nordisk Inc | $15.70 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100483395 | CMS |
| Novo Nordisk Inc | $14.86 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100616033 | CMS |
| Novo Nordisk Inc | $3.47 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100458746 | CMS |
| PFIZER INC. | $14.97 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130883386 | CMS |
| QOL Medical, LLC | $22.02 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147740605 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.